跳至主要内容
临床试验/ACTRN12621001239853
ACTRN12621001239853已完成3 期

Effectiveness of intravenous iron administered during the third trimester in Malawian women in the management of anaemia: a 4-year, multicentre, parallel-group, two-arm, open-label randomised controlled superiority trial

Training and Research Unit of Excellence (TRUE), Malawi0 个研究点目标入组 590 人开始时间: 2021年9月14日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
590

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Confirmed singleton pregnancy in the third trimester (27-35 weeks of gestation, dated by Last Menstrual Period)
  • Moderate to severe anaemia not requiring an immediate blood transfusion (Hb <10 g/dl)
  • Negative malaria parasitaemia by mRDT
  • Currently afebrile with no evidence of septicaemia
  • Resident in the study catchment area of Zomba district (Malawi)
  • Able to deliver at health facilities within Zomba district (Malawi)
  • Written informed consent (including assent if <18 years old)

排除标准

  • Previous enrolment in REVAMP trial – ACTRN12618001268235.
  • Actively participating in another intervention trial.
  • Known hypersensitivity to any of the study drugs.
  • Clinical symptoms of malaria or other infection (no fever, no focal symptoms of internal infection i.e. LRTI/ diarrhoea).
  • Any condition requiring hospitalisation in the next seven days or serious concomitant illness.
  • Known history of sickle cell or sickle-haemoglobin C anaemia.
  • Clinically low haemoglobin level requiring a blood transfusion (usually Hb <5g/dl).
  • Preeclampsia

研究者

发起方
Training and Research Unit of Excellence (TRUE), Malawi

相似试验